United States Biotechnology & Medical Research

Paratek Pharmaceuticals Inc (PRTK)

Track

Ticker: PRTK Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Paratek Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 9 Aug 2023
Value US$1,478,492.24 | Price 54.07 | Shares 28,075 (+49.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-10 2023-08-09 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
28,075 +49.3%
54.07
US$1,478,492 		28,075 +49.3% 54.07 US$1,478,492
2023-08-10 2023-08-09 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
29,630 -29.9%
425.76
US$2,936,743 		29,630 -29.9% 425.76 US$2,936,743
2023-08-10 2023-08-09 S Sale
2.8
Loh Evan

CEO

Executive Director
33,352 +30.0%
120.05
US$3,058,880 		33,352 +30.0% 120.05 US$3,058,880
2023-08-10 2023-08-09 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
31,250 -2.3%
2.20
US$68,750 		31,250 -2.3% 2.20 US$68,750
2023-03-29 2023-03-23 B Purchase
2.4
DONDERO JAMES D
Large shareholder
100,000 +4.9%
1.73
US$173,000 		100,000 +4.9% 1.73 US$173,000
2023-03-29 2023-03-22 B Purchase
2.4
DONDERO JAMES D
Large shareholder
106,000 +5.4%
1.77
US$187,620 		106,000 +5.4% 1.77 US$187,620
2023-03-29 2023-03-21 B Purchase
2.4
DONDERO JAMES D
Large shareholder
242,500 +22.8%
1.74
US$421,950 		242,500 +22.8% 1.74 US$421,950
2023-03-29 2023-03-20 B Purchase
2.4
DONDERO JAMES D
Large shareholder
105,137 +4.9%
1.40
US$147,192 		105,137 +4.9% 1.40 US$147,192
2023-03-29 2023-03-17 B Purchase
2.4
DONDERO JAMES D
Large shareholder
234,863 +12.4%
1.50
US$352,294 		234,863 +12.4% 1.50 US$352,294
2023-02-23 2023-02-21 PlS Planned sale
2.8
Stein Jeffrey
Non-Executive Director
7,000 -9.3%
1.90
US$13,300 		7,000 -9.3% 1.90 US$13,300
2023-02-23 2023-02-21 PlS Planned sale
0.6
Franson Timothy R
Non-Executive Director
7,000 -8.9%
1.88
US$13,160 		7,000 -8.9% 1.88 US$13,160
2022-12-22 2022-12-21 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
4,539 -1.3%
1.99
US$9,033 		4,539 -1.3% 1.99 US$9,033
2022-12-22 2022-12-21 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
15,750 -1.3%
1.99
US$31,342 		15,750 -1.3% 1.99 US$31,342
2022-12-22 2022-12-21 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
23,489 -1.9%
1.99
US$46,743 		23,489 -1.9% 1.99 US$46,743
2022-12-22 2022-12-21 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
7,007 -1.7%
1.99
US$13,944 		7,007 -1.7% 1.99 US$13,944
2022-12-22 2022-12-21 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
6,750 -1.0%
1.99
US$13,432 		6,750 -1.0% 1.99 US$13,432
2022-12-14 2022-12-13 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
6,253 -1.0%
1.96
US$12,256 		6,253 -1.0% 1.96 US$12,256
2022-12-14 2022-12-13 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
23,584 -5.6%
1.96
US$46,225 		23,584 -5.6% 1.96 US$46,225
2022-12-14 2022-12-13 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
61,919 -5.0%
1.96
US$121,361 		61,919 -5.0% 1.96 US$121,361
2022-12-14 2022-12-13 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
18,177 -5.3%
1.96
US$35,627 		18,177 -5.3% 1.96 US$35,627
2022-12-14 2022-12-13 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
31,891 -2.6%
1.96
US$62,506 		31,891 -2.6% 1.96 US$62,506
2022-12-14 2022-12-12 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
3,820 -0.6%
1.98
US$7,564 		3,820 -0.6% 1.98 US$7,564
2022-12-14 2022-12-12 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
14,410 -3.3%
1.98
US$28,532 		14,410 -3.3% 1.98 US$28,532
2022-12-14 2022-12-12 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
37,831 -3.0%
1.98
US$74,905 		37,831 -3.0% 1.98 US$74,905
2022-12-14 2022-12-12 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
11,105 -3.1%
1.98
US$21,988 		11,105 -3.1% 1.98 US$21,988
2022-12-14 2022-12-12 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
19,484 -1.6%
1.98
US$38,578 		19,484 -1.6% 1.98 US$38,578
2022-11-01 2022-10-28 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
3,516 -1.0%
3.47
US$12,201 		3,516 -1.0% 3.47 US$12,201
2022-11-01 2022-10-28 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
4,563 -0.7%
3.47
US$15,834 		4,563 -0.7% 3.47 US$15,834
2022-11-01 2022-10-28 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
4,382 -1.0%
3.47
US$15,206 		4,382 -1.0% 3.47 US$15,206
2022-11-01 2022-10-28 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
6,000 -0.5%
3.47
US$20,820 		6,000 -0.5% 3.47 US$20,820
2022-11-01 2022-10-28 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
8,805 -0.7%
3.47
US$30,553 		8,805 -0.7% 3.47 US$30,553
2022-08-10 2022-08-09 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
44,519 -3.4%
2.66
US$118,421 		44,519 -3.4% 2.66 US$118,421
2022-08-10 2022-08-09 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
19,608 -5.3%
2.66
US$52,157 		19,608 -5.3% 2.66 US$52,157
2022-08-10 2022-08-09 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
28,637 -2.3%
2.66
US$76,174 		28,637 -2.3% 2.66 US$76,174
2022-08-10 2022-08-09 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
22,453 -4.9%
2.66
US$59,725 		22,453 -4.9% 2.66 US$59,725
2021-12-15 2021-12-15 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
17,178 -4.8%
4.27
US$73,350 		17,178 -4.8% 4.27 US$73,350
2021-12-15 2021-12-15 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
15,780 -5.9%
4.27
US$67,381 		15,780 -5.9% 4.27 US$67,381
2021-12-15 2021-12-15 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
22,624 -4.7%
4.27
US$96,604 		22,624 -4.7% 4.27 US$96,604
2021-12-15 2021-12-15 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
17,819 -2.0%
4.27
US$76,087 		17,819 -2.0% 4.27 US$76,087
2021-12-15 2021-12-15 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
49,259 -5.1%
4.27
US$210,336 		49,259 -5.1% 4.27 US$210,336
2021-12-15 2021-12-14 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
8,312 -2.3%
4.37
US$36,323 		8,312 -2.3% 4.37 US$36,323
2021-12-15 2021-12-14 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
7,635 -2.8%
4.37
US$33,365 		7,635 -2.8% 4.37 US$33,365
2021-12-15 2021-12-14 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
10,946 -2.2%
4.37
US$47,834 		10,946 -2.2% 4.37 US$47,834
2021-12-15 2021-12-14 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
8,622 -0.9%
4.37
US$37,678 		8,622 -0.9% 4.37 US$37,678
2021-12-15 2021-12-14 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
23,834 -2.4%
4.37
US$104,155 		23,834 -2.4% 4.37 US$104,155
2021-12-15 2021-12-13 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
4,876 -1.3%
4.42
US$21,552 		4,876 -1.3% 4.42 US$21,552
2021-12-15 2021-12-13 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
4,479 -1.6%
4.42
US$19,797 		4,479 -1.6% 4.42 US$19,797
2021-12-15 2021-12-13 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
6,422 -1.3%
4.42
US$28,385 		6,422 -1.3% 4.42 US$28,385
2021-12-15 2021-12-13 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
5,059 -0.5%
4.42
US$22,361 		5,059 -0.5% 4.42 US$22,361
2021-12-15 2021-12-13 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
13,983 -1.4%
4.42
US$61,805 		13,983 -1.4% 4.42 US$61,805
2021-06-08 2021-06-04 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
36,654 -3.7%
9.70
US$355,544 		36,654 -3.7% 9.70 US$355,544
2021-06-08 2021-06-04 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
34,364 -3.8%
9.70
US$333,331 		34,364 -3.8% 9.70 US$333,331
2021-06-08 2021-06-04 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
17,182 -3.5%
9.70
US$166,665 		17,182 -3.5% 9.70 US$166,665
2020-12-15 2020-12-14 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
26,063 -4.6%
6.71
US$174,883 		26,063 -4.6% 6.71 US$174,883
2020-12-15 2020-12-14 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
8,760 -6.4%
6.71
US$58,780 		8,760 -6.4% 6.71 US$58,780
2020-12-15 2020-12-14 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
6,842 -3.3%
6.71
US$45,910 		6,842 -3.3% 6.71 US$45,910
2020-12-15 2020-12-14 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
12,855 -4.5%
6.71
US$86,257 		12,855 -4.5% 6.71 US$86,257
2020-12-15 2020-12-14 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
26,415 -4.2%
6.71
US$177,245 		26,415 -4.2% 6.71 US$177,245
2020-12-15 2020-12-11 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
4,814 -2.2%
6.95
US$33,457 		4,814 -2.2% 6.95 US$33,457
2020-12-15 2020-12-11 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
9,045 -3.1%
6.95
US$62,863 		9,045 -3.1% 6.95 US$62,863
2020-12-15 2020-12-11 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
18,585 -2.9%
6.95
US$129,166 		18,585 -2.9% 6.95 US$129,166
2020-12-15 2020-12-11 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
18,337 -3.1%
6.95
US$127,442 		18,337 -3.1% 6.95 US$127,442
2020-12-15 2020-12-11 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
6,164 -4.3%
6.95
US$42,840 		6,164 -4.3% 6.95 US$42,840
2020-11-16 2020-11-13 PlS Planned sale
2.8
Haskel William M.

CLO, General Counsel & Sec.

Officer
6,892 -3.1%
5.93
US$40,870 		6,892 -3.1% 5.93 US$40,870
2020-11-16 2020-11-13 PlS Planned sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
8,357 -5.5%
5.93
US$49,557 		8,357 -5.5% 5.93 US$49,557
2020-11-16 2020-11-13 PlS Planned sale
2.8
Loh Evan

CEO

Executive Director
20,928 -3.1%
5.93
US$124,103 		20,928 -3.1% 5.93 US$124,103
2020-11-16 2020-11-13 PlS Planned sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
15,000 -4.9%
5.93
US$88,950 		15,000 -4.9% 5.93 US$88,950
2020-11-16 2020-11-13 PlS Planned sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
26,250 -4.3%
5.93
US$155,662 		26,250 -4.3% 5.93 US$155,662
2020-05-14 2020-05-12 S Sale
2.8
Haskel William M.

Sr. VP, Sec. & General Counsel

Officer
4,666 -2.3%
4.75
US$22,164 		4,666 -2.3% 4.75 US$22,164
2020-05-14 2020-05-12 S Sale
2.7
BIGHAM MICHAEL

Exec. Chairman of the Board

Executive Director
12,250 -2.2%
4.68
US$57,330 		12,250 -2.2% 4.68 US$57,330
2020-05-14 2020-05-12 S Sale
2.8
Brenner Randall B.

Chief Development & Regulatory

Officer
6,198 -4.5%
4.75
US$29,440 		6,198 -4.5% 4.75 US$29,440
2020-05-14 2020-05-12 S Sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
4,798 -1.7%
4.75
US$22,790 		4,798 -1.7% 4.75 US$22,790
2020-05-14 2020-05-12 S Sale
2.8
Loh Evan

CEO

Executive Director
9,595 -1.7%
4.75
US$45,576 		9,595 -1.7% 4.75 US$45,576
2019-12-16 2019-12-12 S Sale Haskel William M.

Sr. VP, Sec. & General Counsel

Officer
2,864 -1.8%
3.10
US$8,878 		2,864 -1.8% 3.10 US$8,878
2019-12-16 2019-12-12 S Sale
2.8
Woodrow Adam

President & Chief Commercial

Officer
4,401 -2.1%
3.10
US$13,643 		4,401 -2.1% 3.10 US$13,643
Explore more

More insider trading research around Paratek Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America